← Back to directory

Christophe Pannecouque

Researcher Next ID · RN-039595

Researcher · Chemistry

Rega Institute for Medical Research

Leuven, Belgium

Accepting doctoral researchersFunding unknown
Works count
754
Citation count
20,881
H-index
72
i10-index
444

Research interests

Chemistry
Immunology and Microbiology
Medicine
HIV/AIDS drug development and treatment
HIV Research and Treatment
Click Chemistry and Applications
Pneumocystis jirovecii pneumonia detection and treatment
Synthesis and Characterization of Heterocyclic Compounds

Publications

  • Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses

    Chemical Society Reviews · 2021 · 10.1039/d0cs01084g

  • Development of non-nucleoside reverse transcriptase inhibitors (NNRTIs): our past twenty years

    Acta Pharmaceutica Sinica B · 2019 · 10.1016/j.apsb.2019.11.010

  • Overview of Recent Strategic Advances in Medicinal Chemistry

    Journal of Medicinal Chemistry · 2019 · 10.1021/acs.jmedchem.9b00359

  • Graphene Quantum Dots Based Systems As HIV Inhibitors

    Bioconjugate Chemistry · 2018 · 10.1021/acs.bioconjchem.8b00448

  • Bioactive Natural Products Prioritization Using Massive Multi-informational Molecular Networks

    ACS Chemical Biology · 2017 · 10.1021/acschembio.7b00413

  • Design, Synthesis, and Evaluation of Thiophene[3,2-d]pyrimidine Derivatives as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Drug Resistance Profiles

    Journal of Medicinal Chemistry · 2016 · 10.1021/acs.jmedchem.6b00738

  • Design and Synthesis of DiselenoBisBenzamides (DISeBAs) as Nucleocapsid Protein 7 (NCp7) Inhibitors with anti-HIV Activity

    Journal of Medicinal Chemistry · 2015 · 10.1021/acs.jmedchem.5b01183

  • Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends

    Journal of Medicinal Chemistry · 2015 · https://doi.org/10.1021/acs.jmedchem.5b00497

  • Anti-HIV-1 activity of the G-quadruplex ligand BRACO-19

    Journal of Antimicrobial Chemotherapy · 2014 · 10.1093/jac/dku280

  • Indolylarylsulfones as HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: New Cyclic Substituents at Indole-2-carboxamide

    Journal of Medicinal Chemistry · 2011 · 10.1021/jm101614j

  • A time-of–drug addition approach to target identification of antiviral compounds

    Nature Protocols · 2011 · 10.1038/nprot.2011.330

  • A 1,8-Naphthyridone Derivative Targets the HIV-1 Tat-Mediated Transcription and Potently Inhibits the HIV-1 Replication

    Journal of Medicinal Chemistry · 2009 · 10.1021/jm901211d

  • Synthesis and antiviral activity of new pyrazole and thiazole derivatives

    European Journal of Medicinal Chemistry · 2009 · https://doi.org/10.1016/j.ejmech.2009.03.038

  • Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later

    Nature Protocols · 2008 · 10.1038/nprot.2007.517

  • Improved and rapid synthesis of new coumarinyl chalcone derivatives and their antiviral activity

    Tetrahedron Letters · 2007 · 10.1016/j.tetlet.2007.09.175

  • Synthesis and evaluation of 2-(2,6-dihalophenyl)-3-pyrimidinyl-1,3-thiazolidin-4-one analogues as anti-HIV-1 agents

    Bioorganic & Medicinal Chemistry · 2007 · 10.1016/j.bmc.2007.02.044

  • Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle

    Antiviral Research · 2007 · 10.1016/j.antiviral.2007.03.003

  • Design, synthesis, and evaluation of 2-aryl-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents

    Bioorganic & Medicinal Chemistry · 2006 · 10.1016/j.bmc.2006.12.003

  • Susceptibility of HIV-2, Siv and Shiv to Various Anti-HIV-1 Compounds: Implications for Treatment and Postexposure Prophylaxis

    Antiviral Therapy · 2004 · 10.1177/135965350400900115

  • Synthesis and antiviral activity evaluation of some new 6-substituted 3-(1-adamantyl)-1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles

    Il Farmaco · 2002 · 10.1016/s0014-827x(01)01189-2

  • Design, Synthesis, Structure−Activity Relationships, and Molecular Modeling Studies of 2,3-Diaryl-1,3-thiazolidin-4-ones as Potent Anti-HIV Agents

    Journal of Medicinal Chemistry · 2002 · 10.1021/jm020977+

  • Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agents

    Bioorganic & Medicinal Chemistry Letters · 2001 · 10.1016/s0960-894x(01)00304-3

  • Antiviral activity against human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) of ethnobotanically selected Ethiopian medicinal plants

    Phytotherapy Research · 2001 · 10.1002/1099-1573(200102)15:1<62::aid-ptr956>3.0.co;2-x

  • Polyanionic (i.e., Polysulfonate) Dendrimers Can Inhibit the Replication of Human Immunodeficiency Virus by Interfering with Both Virus Adsorption and Later Steps (Reverse Transcriptase/Integrase) in the Virus Replicative Cycle

    Molecular Pharmacology · 2000 · 10.1124/mol.58.5.1100

  • Chicoric Acid Analogues as HIV-1 Integrase Inhibitors

    Journal of Medicinal Chemistry · 1999 · 10.1021/jm980531m

Current projects

    No projects listed.